There was significant improvement in ESR, CRP, and RF in both groups after treatment (CRP and RF, treatment group, P < 0.01; control group, P < 0.05; ESR, both groups P < 0.01), which indicated that ESR, CRP, and RF of RA patients in both groups decreased after treatment. This evidence concerns the gene ESR1 and rheumatoid arthritis.